Inspiremd Stock In The News

NSPR Stock  USD 2.39  0.02  0.83%   
Our overall analysis of InspireMD's news coverage and content from conventional and social sources shows investors' bearish mood towards InspireMD. The specific impact of InspireMD news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of InspireMD's overall financial health and prospects. It also depends on the type and quality of a news publisher. Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using InspireMD headlines in addition to utilizing other, more conventional financial analysis modules. Check out InspireMD Backtesting and InspireMD Hype Analysis.
To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.

InspireMD Today Top News and Investor Outlook

Yahoo News
InspireMD Launches CGuard Prime Carotid Stent System in the U.S.
https://finance.yahoo.com/news/inspiremd-launches-cguard-prime-carotid-135700508.html
 Bullish
Investing News at Macroaxis
InspireMD launches CGuard Prime carotid stent in US after FDA approval
https://www.investing.com/news/company-news/inspiremd-launches-cguard-prime-carotid-stent-in-us-after-fda-approval-93CH-4127920
 Bullish
Macroaxis News: globenewswire.com
InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke
https://www.globenewswire.com/news-release/2025/06/24/3104650/0/en/InspireMD-Announces-FDA-Approval-for-CGuard-Prime-Carotid-Stent-System-for-the-Prevention-of-Stroke.html
 Neutral
Macroaxis News: globenewswire.com
InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke
https://www.globenewswire.com/news-release/2025/06/13/3099029/0/en/InspireMD-Announces-CE-Mark-Approval-for-CGuard-Prime-Embolic-Prevention-System-EPS-Under-European-MDR-for-the-Prevention-of-Stroke.html
 Neutral
Macroaxis News: globenewswire.com
InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer
https://www.globenewswire.com/news-release/2025/06/03/3093191/0/en/InspireMD-Announces-Appointment-of-Michael-Lawless-as-Chief-Financial-Officer.html
 Bullish
Macroaxis News: globenewswire.com
InspireMD Reports First Quarter 2025 Financial Results
https://www.globenewswire.com/news-release/2025/05/09/3078099/0/en/InspireMD-Reports-First-Quarter-2025-Financial-Results.html
 Bullish
Macroaxis News: globenewswire.com
InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference
https://www.globenewswire.com/news-release/2025/04/30/3071367/0/en/InspireMD-to-Present-at-Upcoming-Bank-of-America-2025-Healthcare-Conference.html
 Neutral
Macroaxis News: globenewswire.com
InspireMD to Announce First Quarter 2025 Financial Results
https://www.globenewswire.com/news-release/2025/04/25/3068311/0/en/InspireMD-to-Announce-First-Quarter-2025-Financial-Results.html
 Bullish
Macroaxis News: globenewswire.com
InspireMD and NAMSA to Partner on CGUARD...
https://www.globenewswire.com/news-release/2025/02/13/3025749/0/en/InspireMD-and-NAMSA-to-Partner-on-CGUARDIANS-II-Pivotal-Clinical-Trial-of-the-CGuard-Prime-80-cm-Carotid-Stent-System-for-Use-in-TCAR-procedures.html
 Neutral
Macroaxis News: globenewswire.com
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
https://www.globenewswire.com/news-release/2025/02/04/3020133/0/en/InspireMD-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
 Neutral

InspireMD Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide InspireMD and other traded companies coverage with news coverage. We help investors stay connected with InspireMD headlines for the 20th of July to make an informed investment decision based on correlating the impacts of news items on InspireMD Stock performance. Please note that trading solely based on the InspireMD hype is not for everyone as timely availability and quick action are needed to avoid losses.
InspireMD's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help InspireMD investors visualize upcoming and past events in order to time the market based on InspireMD noise-free hype analysis.

InspireMD Investors Sentiment

The influence of InspireMD's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in InspireMD. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to InspireMD's public news can be used to forecast risks associated with an investment in InspireMD. The trend in average sentiment can be used to explain how an investor holding InspireMD can time the market purely based on public headlines and social activities around InspireMD. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
InspireMD's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for InspireMD's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average InspireMD's news discussions. The higher the estimated score, the more favorable is the investor's outlook on InspireMD.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards InspireMD in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, InspireMD's short interest history, or implied volatility extrapolated from InspireMD options trading.

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.